Genertec Universal Medical Group Company Limited (5UM) — Capital Reinvestment Ratio
Genertec Universal Medical Group Company Limited (5UM) has a Capital Reinvestment Ratio of 0.10x as of December 2022, meaning it reinvests 0% of its operating cash flow (€1.69 Billion) in capital expenditures (€170.49 Million). Check tangible equity quality of Genertec Universal Medical Group Company to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genertec Universal Medical Group Company Limited Capital Reinvestment Ratio (2022–2025)
This chart tracks Genertec Universal Medical Group Company Limited's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see 5UM operating cash flow.
Annual Capital Reinvestment Ratio for Genertec Universal Medical Group Company Limited (2022–2025)
Year-by-year Capital Reinvestment Ratio for Genertec Universal Medical Group Company Limited from 2022 to 2025. See Genertec Universal Medical Group Company free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | €5.78 Billion | €988.91 Million | ▼ -84.5% |
| 2024 | 1.10x | €1.14 Billion | €1.26 Billion | ▲ +514.0% |
| 2023 | 0.18x | €4.99 Billion | €896.83 Million | ▼ -39.2% |
| 2022 | 0.30x | €2.06 Billion | €608.09 Million | — |